Aparna Parvathi

Dedicated GA-licensed pharmacist with a versatile background in providing patient-centered care within highly challenging inpatient settings and retail pharmacy.. Skilled in assessing evidence-based information to accurately prepare and dispense medications, offering clinical guidance to the public, and managing inventory with precision. Possessing a Doctorate in Pharmacy and a Bachelor's degree in Biological Sciences. Currently leveraging expertise as a Full-Time Pharmacist at Arthur M. Blank Hospital. Enthusiastic about entering into a niche pharmacy role to further augment and strengthen my current skills and experiences by involving in an alternative pharmacy practice, prioritizing patient safety, facilitating patient health with compassion and advancing healthcare within a patient-focused environment. Equipped with strong problem-solving abilities, willingness to learn, and excellent communication skills. Poised to contribute to team success and achieve positive results. Ready to tackle new challenges and advance organizational objectives with dedication and enthusiasm.

Pharmacist License Georgia Board of Pharmacy September 2022

Cardiopulmonary Resuscitation/Basic Life Support June 2024

Medication Therapy Management American Pharmacists Association September 2020

Pharmacy Based Immunization Certificate American Pharmacists Association April 2019

Transplant Pharmacy Emory University Hospital Atlanta, GA March 2022 - April 2022

Preceptor: Michael Hurtik

• Prepared review of up to 20 patients daily and presented pertinent information as daily patient workups
• Counseled patients on self-administration, indication, side effects and self-monitoring for new initiation of transplant medications
• Prepared presentation for education of pharmacists on Depression and Anxiety

Ambulatory Care Grady Memorial Hospital Atlanta, GA November 2021 - December 2021

Preceptor: Sweta Patel, PharmD, BCPS

• Assessed and adjusted drug therapies and doses for patients with chronic disease states such as diabetes, hypertension, and hyperlipidemia
• Completed manuscript review for journal of ambulatory care
• Reviewed an average of 6 to 8 patients for scheduled DOAC clinic appointment to monitor for side effects, provide counseling, and ensure adherence.

Evaluation of Weight-Based Enoxaparin Dosing for Prevention and Treatment of Thrombosis in COVID-19 Patients at a Community Hospital. May 2021 - December 2021

• Conducted retrospective chart review of 76 patients with confirmed COVID-19 who received risk stratified weight-based dosing of enoxaparin from 12/01/2020-06/30/2021
• Determined the incidence of bleeding and thrombosis in obese and non-obese COVID-19 patients who received weight-based intermediate or therapeutic dose of enoxaparin
• Presented at ASHP Midyear for December 7, 2021